MedPath

Attapulgite

Generic Name
Attapulgite
Drug Type
Small Molecule
Chemical Formula
AlH9MgO15Si4
CAS Number
12174-11-7
Unique Ingredient Identifier
U6V729APAM

Overview

Attapulgite is a magnesium aluminium phyllosilicate which occurs in a type of clay soil common to the Southeastern United States. When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. Until 2003, it was the active ingredient used in Kaopectate, before that product was reformulated with bismuth subsalicylate.

Indication

When used in medicine, it physically binds to acids and toxic substances in the stomach and digestive tract. For that reason, it has often been used in antidiarrheal medications. Attapulgite is an adsorbent.

Associated Conditions

  • Acute Diarrhea
  • Diarrhea

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
DIBAN CAP
wyeth-ayerst canada inc.
02041626
Capsule - Oral
300 MG
2/18/1998
KAOPECTATE LIQ 600MG/15ML
upjohn consumer products company
00836656
Liquid - Oral
600 MG / 15 ML
12/31/1989
DIARET TAB
produits francais labs inc.
00540862
Tablet - Oral
350 MG / TAB
12/31/1981
CHILDREN'S KAOPECTATE SUS 600MG/15ML
upjohn consumer products company
01951165
Suspension - Oral
600 MG / 15 ML
12/31/1992
KAOPECTATE CHEWABLE TABLETS 300MG
johnson & johnson - merck consumer pharmaceuticals of canada
02229948
Tablet - Oral
300 MG
9/18/1998
KAOPECTATE TABLETS 600MG
the upjohn company of canada
00730955
Tablet - Oral
600 MG / TAB
12/31/1989
DIBAN CAP
ayerst laboratories
01909215
Capsule - Oral
300 MG
12/31/1992
DIAREX TAB
nutribon (1986) inc.
02003392
Tablet - Oral
350 MG / TAB
12/31/1995
KAOPECTATE CHEWABLE TAB 300MG
upjohn consumer products company
00875058
Tablet - Oral
300 MG
12/31/1990
KAOPECTATE TABLET - 600MG
johnson & johnson - merck consumer pharmaceuticals of canada
02229953
Tablet - Oral
600 MG
7/24/1998

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.